First record of a possible trypanotolerant cattle breed in Latin America: Parasitological, serological, and clinical aspects

被引:0
|
作者
de Mendonca, Debora Ribeiro [1 ]
Couto, Luiz Fellipe Monteiro [1 ]
Pureza, Luana Hernandez [1 ]
Martins, Danieli Brolo [1 ]
Soares, Vando Edesio [2 ]
Ferreira, Lorena Lopes [3 ]
Fioravanti, Maria Clorinda Soares [1 ]
Bastos, Thiago Souza Azeredo [1 ]
da Cunha, Paulo Henrique Jorge [1 ]
Lopes, Welber Daniel Zanetti [1 ,4 ]
机构
[1] Univ Fed Goias, Escola Vet & Zootecnia, Goiania, GO, Brazil
[2] Univ Brasil, Descalvado, SP, Brazil
[3] Univ Fed Minas Gerais, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil
[4] Univ Fed Goias, Dept Biociencias & Tecnol, Inst Patol Trop & Saude Publ, Goiania, GO, Brazil
关键词
Cattle; Curraleiro Pe<acute accent>-Duro; Packed cell volume; Parasitemia; Trypanosoma vivax; Trypanosomosis; Trypanotolerance; TRYPANOSOMA-VIVAX; AFRICAN TRYPANOSOMIASIS; ANIMAL TRYPANOSOMIASIS; SOUTH-AMERICA; RESISTANCE; STATE; SUSCEPTIBILITY; LIVESTOCK; OUTBREAK; NDAMA;
D O I
10.1016/j.vprsr.2024.101090
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Trypanosoma vivax infections are endemic in Africa, where they provoke trypanosomosis against which some local taurine breeds are tolerant and are thus named trypanotolerant. In Latin America, T. vivax was imported in 1919, since when it has been responsible for periodic outbreaks of the disease. This study assessed whether a South American taurine breed resilient to several parasitic and infectious diseases (Curraleiro Pe<acute accent>-Duro-CPD) can meet trypanotolerant criteria (control parasite proliferation, prevent anemia, survive without treatment, and maintain productivity). Three groups were established, each consisting of six animals (Group 1: CPD-infected; Group 2: Holstein/Gyr-infected; Group 3: Holstein/Gyr-uninfected, negative control). Groups 1 and 2 were infected with T. vivax on Day 0 and evaluated until day 532. Throughout the experimental period, parasitological (Woo and Brener), molecular (cPCR), serological (enzyme-linked immunosorbent assay - ELISA, indirect fluorescent antibody test - IFAT, immunochromatographic assay - IA), and clinical (hemogram, fever, weight loss) aspects were evaluated. During the acute phase of the disease, T. vivax was initially detected in Holstein/Gyr. Notably, the CPD animals restored their packed cell volume (PCV) values to the normal range 74 days after inoculations. In the chronic phase, two of the six CPD animals were positive by cPCR until D + 522 following immunosuppression with dexamethasone. Regarding serological aspects, the two CPD animals had positive tests until D + 532. The absence of T. vivax in blood during the chronic phase did not correspond to "self-cure". Holstein/Gyr animals exhibited fever on more evaluation days than CPD animals. Both breeds experienced weight loss, with Holstein/Gyr animals losing significantly more weight. On D + 25, the Holstein/Gyr group required treatment. During the 532 days, none of the CPD animals required treatment, even after being sensitized with dexamethasone. Animals from Group 3 tested negative for T. vivax throughout the experiment. This study demonstrated that CPD cattle fulfill the mentioned trypanotolerant criteria.
引用
收藏
页数:9
相关论文
共 25 条
  • [11] First report of IMP-1 in a clinical isolate of Escherichia coli in Latin America
    Wink, Priscila Lamb
    Almeida, Evelyn Kern
    Crispim, Marina Niada
    de Lima-Morales, Daiana
    Zavascki, Alexandre P.
    Barth, Afonso Luis
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (08): : 997 - 998
  • [12] First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia
    Calvo, Belinda
    Melo, Analy S. A.
    Perozo-Mena, Armindo
    Hernandez, Martin
    Francisco, Elaine Cristina
    Hagen, Ferry
    Meis, Jacques F.
    Colombo, Arnaldo Lopes
    JOURNAL OF INFECTION, 2016, 73 (04) : 369 - 374
  • [13] A large abnormal mass of granulation tissue in the heart of an Iranian cross-breed cattle: Clinical, hematological and pathological findings (first report)
    Mozaffari A.A.
    Derakhshanfar A.
    Comparative Clinical Pathology , 2011, 20 (5) : 539 - 541
  • [14] Good Clinical Practices (GCP) in Latin America: Prospects for Regional Harmonization: A Challenge for the Twenty-First Century
    Nanci Bergamo
    Vivian de Trespalacios
    Maria L. Marquez
    Silvia Perez
    Sylvia Samaniego
    Eric Vander Elst
    Drug information journal : DIJ / Drug Information Association, 2001, 35 (1): : 27 - 34
  • [15] Good Clinical Practices (GCP) in Latin America: Prospects for regional harmonization: A challenge for the twenty-first century
    Bergamo, N
    de Trespalacios, V
    Marquez, ML
    Perez, S
    Samaniego, S
    Vander Elst, E
    DRUG INFORMATION JOURNAL, 2001, 35 (01): : 27 - 34
  • [16] Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa
    Guelbert, Norberto
    Segura, Oscar Mauricio Espitia
    Amoretti, Carolina
    Arteaga, Angelica Arteaga
    Atanacio, Nora Graciela
    Natacha, Sabrina Bazan
    Carvalho, Ellaine Doris Fernandes
    Andrade, Maria Denise Fernandes Carvalho de
    Denzler, Ines Maria
    Durand, Consuelo
    Ribeiro, Erlane
    Giugni, Juan Carlos
    Gonzalez, Gabriel
    Moron, Dolores Gonzalez
    Guelbert, Guillermo
    Rodriguez, Zulma Janneth Hernandez
    Emilia, Katiane Embirucu
    Kauffman, Marcelo Andres
    Mancilla, Nury Isabel
    Marcon, Laureano
    Pereira, Alessandra Marques
    Souza, Carolina Fischinger Moura de
    Munoz, Victor Adrian
    Florez, Ricardo Andres Naranjo
    Pessoa, Andre Luiz
    Ruiz, Maria Victoria
    Villareal, Martha Luz Solano
    Specola, Norma
    Tavera, Lina Marcela
    Tello, Javiera
    Schifferli, Monica Troncoso
    Ugrina, Sonia
    Vaccarezza, Maria Magdalena
    Vergara, Diane
    Villanueva, Maria Mercedes
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2024, 38
  • [17] Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study
    Angriman, Federico
    Belloso, Waldo H.
    Sierra-Madero, Juan
    Sanchez, Jorge
    Moreira, Ronaldo Ismerio
    Kovalevski, Leandro O.
    Orellana, Liliana C.
    Cardoso, Sandra Wagner
    Crabtree-Ramirez, Brenda
    La Rosa, Alberto
    Losso, Marcelo H.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (02) : 118 - 126
  • [18] A RETROSPECTIVE MEDICAL RECORD REVIEW OF FIRST-LINE SUNITINIB ADMINISTRATION SCHEDULES AND OUTCOMES AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN LATIN AMERICA
    Jimenez, M.
    Zanotti, G.
    Parikh, R. C.
    Esterberg, E.
    Suarez, L. A.
    VALUE IN HEALTH, 2023, 26 (06) : S45 - S45
  • [19] Clinical and serological profile of asymptomatic and non- severe symptomatic COVID-19 cases: Lessons from a longitudinal study in primary care in Latin America
    Puschel, Klaus
    Ferreccio, Catterina
    Penaloza, Blanca
    Abarca, Katia
    Rojas, Maria-Paulina
    Tellez, Alvaro
    Moore, Philippa
    Maria Cea, Ana
    Wilson, Carlos
    Cid, Vicente
    Montero, Joaquin
    BJGP OPEN, 2021, 5 (01) : 1 - 8
  • [20] First characterization of K. pneumoniae ST11 clinical isolates harboring blaKPC-3 in Latin America
    Garcia-Fulgueiras, Virginia
    Zapata, Yuliana
    Papa-Ezdra, Romina
    Avila, Pablo
    Caiata, Leticia
    Seija, Veronica
    Rojas Rodriguez, Ana E.
    Magallanes, Carmen
    Villalba, Carolina Marquez
    Vignoli, Rafael
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2020, 52 (03): : 211 - 216